Rocket Pharmaceuticals' Gene Therapy Progress Boosts Confidence in Future Developments: Analyst
On Monday, Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) presented long-term safety and efficacy results from the Phase 1 study ...
Promising results from phase 1 gene therapy trial for Danon disease
Researchers at Children's Hospital of Philadelphia (CHOP) announced encouraging results from the first ever gene therapy ...
STAT18h
The FDA’s risky action on compounding weight loss drugs
The FDA’s decision to allow the compounding of GLP-1 weight loss drugs could undermine its public health obligations, writes ...
STAT19h
Two drugs look promising for lipoprotein(a), a common genetic risk factor for heart disease
At AHA, Phase 2 results from Eli Lilly and Silence Therapeutics are seen as signs of a "major new path" of cardiovascular ...
National Post18h
Breaking News, Headlines and Stories | National Post
This advertisement has not loaded yet, but your article continues below. New sites would require government's approval Two men on Monday will face trial on human smuggling charges, accused of ...
Indiatimes6h
Tech Mahindra Share Price
Tech Mahindra Ltd., incorporated in the year 1986, is a Large Cap company (having a market cap of Rs 1,65,096.49 Crore) operating in IT Software sector. Tech Mahindra Ltd. key Products/Revenue ...